Stada welcomes German decision on doxylamine

2 March 2022 - Deborah Wilkes

Premium

Stada has welcomed a decision by the German health ministry to allow the antihistamine doxylamine to remain available without a prescription for use by people of all ages with sleep disorders, including those aged 65 years and older.

Click tags below for more information on topics:

Stada

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: